Tirzepatide is a medication that acts on both GIP and GLP-1 receptors. Amla provides access to clinician review for compounded tirzepatide where available and legally appropriate. Treatment and dosing are personalized based on the patient’s intake and clinical review. To ask whether it is an option for you, contact your clinician through https://portal.amlawellness.com/login.